Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
| Autor: | Yachnin, Jeffrey, Gilje, Bjørnar, Thon, Kristian, Johansson, Hemming, Brandberg, Yvonne, Panaretakis, Theocharis, Ullén, Anders |
|---|---|
| Zdroj: | In European Journal of Cancer July 2018 97:33-40 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect